NYSE:NVO Novo Nordisk A/S Q3 2026 Earnings Report $37.49 -0.05 (-0.13%) Closing price 10/6/2026 03:59 PM EasternExtended Trading$37.52 +0.03 (+0.08%) As of 08:25 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. ProfileEarnings HistoryForecast Novo Nordisk A/S EPS ResultsActual EPSN/AConsensus EPS $0.76Beat/MissN/AOne Year Ago EPSN/ANovo Nordisk A/S Revenue ResultsActual RevenueN/AExpected Revenue$11.12 billionBeat/MissN/AYoY Revenue GrowthN/ANovo Nordisk A/S Announcement DetailsQuarterQ3 2026Date11/4/2026TimeBefore Market OpensConference Call DateWednesday, November 4, 2026Conference Call Time7:00AM ETConference Call ResourcesEarnings HistoryCompany Profile Novo Nordisk A/S Earnings HeadlinesNovo Stock Is Down More Than 70% From Its Peak. Value Trap or Generational Buying Opportunity?October 6 at 8:15 PM | fool.comNovo Looks Beyond GLP-1s as Competition IntensifiesOctober 5 at 1:52 PM | finance.yahoo.comTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result.October 7 at 1:00 AM | Porter & Company (Ad)CN Bio Announces Expert Speaker Line-Up and Scientific Program for Inaugural Organ-on-a-Chip e-SymposiumOctober 5 at 1:52 PM | finance.yahoo.comType 2 Diabetes Market to Grow Significantly During the Forecast Period (2026–2036), with Rising Prevalence and Increasing Uptake of Next-Generation Therapies | DelveInsightOctober 5 at 1:52 PM | finance.yahoo.comNovo Looks Beyond GLP-1s as Competition IntensifiesOctober 5 at 9:51 AM | insidermonkey.comSee More Novo Nordisk A/S Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Novo Nordisk A/S? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Novo Nordisk A/S and other key companies, straight to your email. Email Address About Novo Nordisk A/SNovo Nordisk A/S (NYSE:NVO) is a Denmark-based global pharmaceutical company focused on treatments for diabetes, obesity and other serious chronic diseases. Its portfolio includes injectable and oral medicines for diabetes, including insulin products and the GLP-1 therapies Ozempic and Rybelsus, as well as the obesity treatment Wegovy. The company also develops and markets products for rare blood disorders, including hemophilia, along with growth hormone therapies and hormone replacement treatments. Novo Nordisk conducts research in areas such as cardiometabolic disease and related chronic conditions, and serves patients and healthcare providers across markets worldwide. Novo Nordisk traces its origins to two Danish companies, Nordisk Insulinlaboratorium and Novo Terapeutisk Laboratorium, founded in the 1920s. The businesses merged in 1989 to form Novo Nordisk. The company is headquartered in Bagsværd, Denmark, and its shares trade on Nasdaq Copenhagen, while its American depositary receipts trade on the New York Stock Exchange under the symbol NVO.View Novo Nordisk A/S ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Lamb Weston’s Turnaround Is Starting to Look RealAI Chip Demand Gives Linde a New Growth CatalystAllient’s Data Center and Defense Momentum Is Raising the StakesInvenTrust’s Sell-Off Opens a Potential Entry PointCuraleaf’s Higher Aurora Bid Raises the Stakes in Cannabis Consolidation3 Low-Rated Stocks Analysts May Be Underestimating Ahead of Q3 EarningsNVIDIA’s Record High Raises a Bigger Question About How Far the Rally Can Run Upcoming Earnings PepsiCo (10/8/2026)Delta Air Lines (10/9/2026)Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026)Wells Fargo & Company (10/13/2026)Johnson & Johnson (10/13/2026)UnitedHealth Group (10/13/2026)Bank of America (10/14/2026)BlackRock (10/14/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
